Financial Statements · Financial Reporting

Narafarm OÜ

Official identifier 12139312Record date 31 Dec 2020
Estonia

Report

Legal form
OÜ
Report status
Registered

Dates

Reporting year
2020
Period start
1 Jan 2020
Submitted date
4 Aug 2021

Report

Consolidated
No
Audited
No

Financial metrics

StatementMetricValue
Bilanss, detailneAssets520,917
Bilanss, detailneCash and cash equivalents9,671
Bilanss, detailneCurrent assets87,923
Bilanss, detailneCurrent liabilities68,583
Bilanss, detailneEquity371,226
Bilanss, detailneShare capital at nominal value2,500
Bilanss, detailneNon-current assets432,994
Bilanss, detailneNon-current liabilities81,108
Bilanss, detailneRetained earnings (loss) from previous periods269,186
Income statement scheme 1Depreciation and impairment of non-current assets-47,901
Income statement scheme 1Labour costs-17,274
Income statement scheme 1Revenue207,736
Income statement scheme 1Annual period profit / loss99,290
Income statement scheme 1Operating profit (loss)102,722
Income statement scheme 1Profit (loss) before income tax99,290
Profit distribution proposalRetained earnings (loss) from previous periods269,186
Note: Labour costsEmployees2
Note: Labour costsLabour costs17,274

Linked company

Company: Narafarm OÜ

Source

Estonian e-Business Register Annual Reports open data

View published source

Back to Financial Statements